Evidence map›Paper›PMID 35265148›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Emodin Alleviates High-Glucose-Induced Pancreatic

Yiqian Xing, Yuchi He, Yuan Zhang, Heting Wang, Sihan Peng, Chunguang Xie, Jian Kang, Ya Liu, Xiyu Zhang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. The role of regulated necrosis in diabetes and its complications.Journal of molecular medicine (Berlin, Germany) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yiqian XingChengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
Yuchi HeChengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
Yuan ZhangFirst Affiliated Hospital of Army Medical University, Chongqing 400038, China.
Heting WangDepartment of Traditional Chinese Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
Sihan PengChengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
Chunguang XieTCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
Jian KangDepartment of Anorectal, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
Ya LiuDepartment of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.ORCID https://orcid.org/0000-0002-1949-8430
Xiyu ZhangTCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.ORCID https://orcid.org/0000-0003-3244-3554
Chengdu University of Traditional Chinese Medicine · CNArmy Medical University · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus (DM) is a chronic noninfectious disease that is mainly featured by pancreatic

Identifiers

PMID35265148
PMCPMC8898799
OpenAlexW4214706435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.